While the full impact is impossible to gauge at this time, it will clearly have an impact in the current quarter and beyond.

As we have previously said, the magnitude of the worldwide restructuring program the company is undertaking imposes significant challenges to ensure the appropriate accounting.

This soft revenue performance is seen virtually through all of our businesses. While we are not yet seeing any precipitous decline, we certainly see no signs of a recovery.

Unfortunately, the U.S. economy is showing signs of further slowing, exacerbated by the Sept. 11 attack. We are also beginning to see weakening economic conditions in other countries around the world. In addition, pricing pressures in our health imaging business intensified during the quarter, which combined with operational issues to reduce expected earnings for the quarter.